透過您的圖書館登入
IP:3.14.142.115

摘要


淋巴瘤可能是最常使用治療評估分類 treatment response classifications(完全反應、部分反應、穩定、及疾病惡化)的疾病。2014年發表的 Lugano classification(LC)是自1999年來第二次修訂淋巴瘤的治療評估準則 guideline(第一次修訂是2007年)。本文簡單說明實體腫瘤(solid tumors)及淋巴瘤治療評估的各種標準 criteria,特別著重LC的介紹。

參考文獻


Moghbel MC, Kostakoglu L, Zukotynski K, et al. Response Assessment Criteria and Their Applications in Lymphoma: Part 1. J Nucl Med 2016;57:928-35.
Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer(EORTC)PET Study Group. Eur J Cancer 1999;35:1773-82.
Surbone A, Longo DL, DeVita V, et al. Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management. J Clin Oncol 1988;6:1832-7.
Fuks JZ, Aisner J, Wiernik PH. Restaging laparotomy in the management of the non‐Hodgkin lymphomas. Med Pediatr Oncol 1982;10:429-38.
Mikhaeel N, Timothy A, Hain S, et al. 18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas. Ann Oncol 2000;11:147-50.

延伸閱讀


國際替代計量